Santen Pharmaceutical shares owned by Rhumbline Advisers
Quarter-by-quarter ownership of Santen Pharmaceutical (SNPHY) shares owned by Rhumbline Advisers
from 13F filings
Historical chart of Rhumbline Advisers investment in Santen Pharmaceutical
Tip: Access up to 7 years of quarterly data
All positions including Santen Pharmaceutical held by Rhumbline Advisers consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Santen Pharmaceutical by Rhumbline Advisers
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $14k | 1.2k | 11.27 |
| 2025-06-30 | $348 | 30 | 11.60 |
| 2025-03-31 | $284 | 30 | 9.47 |
| 2024-12-31 | $303 | 30 | 10.10 |
| 2024-09-30 | $363 | 30 | 12.10 |
| 2024-06-30 | $306 | 30 | 10.20 |
| 2024-03-31 | $291 | 30 | 9.73 |
| 2023-12-31 | $294 | 30 | 9.83 |
| 2023-09-30 | $273 | 30 | 9.10 |
| 2023-06-30 | $252 | 30 | 8.43 |
Top funds holding Santen Pharmaceutical
View all funds holding Santen Pharmaceutical